‘Unexplained illness’ puts Johnson & Johnson coronavirus vaccine study on pause

By Zach Halaschak

Published October 13, 2020 1:50am ET

‘Unexplained illness’ puts Johnson & Johnson coronavirus vaccine study on pause — A lab technician working a bottle containing for COVID-19 vaccine testing at Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand, Monday, May 25, 2020. Thai health officials said that scientists in Thailand have had promising results in testing a COVID-19 vaccine candidate on mice, and have begun testing on monkeys. | (Sakchai Lalit/AP)

A coronavirus vaccine study by Johnson & Johnson has been put on pause after one of the study’s participants had an “unexpected illness.”

An independent safety monitoring board will review the patient’s case as will internal clinical and safety physicians, the company said in a Monday evening news release.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

‘Unexplained illness’ puts Johnson & Johnson coronavirus vaccine study on pause

Recommended Stories

Johnson & Johnson vaccine may be linked to anxiety and fainting, according to CDC

Pharmacies say they could handle a massive ramp-up in COVID-19 vaccination distribution but lack supply

FDA greenlights Pfizer vaccine boosters for 16- and 17-year-olds

Full midterm coverage.Deeper analysis.

Tag: